Evasc Neurovascular’s eClips Bifurcation Flow Diverter Launched

October 20, 2021—Evasc Neurovascular announced the introduction of its eClips bifurcation flow diverter, which is the third generation of the company’s eClips device. The company is conducting a limited market launch of the device in the European Union and United States.

According to Evasc, the new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eClips devices. As a result, the eClips bifurcation flow diverter does not require coiling and provides the same unique neck bridging delivery. The new device can cover up to a 6-mm neck length. The eClips bifurcation flow diverter also simplifies deployment with greatly reduced delivery times, noted the company.

The company stated that the newest generation of eClips is designed for more effective treatment of intracranial bifurcation aneurysms with a shapeable delivery wire, a smaller size that is compatible with 0.021- and 0.027-inch inner-diameter microcatheters, and electrolytic detachment.

“We’re excited to see the latest innovation in Evasc Neurovascular’s eClips devices, which will lead to better outcomes for patients and remarkable device delivery time—usually within 10 minutes,” commented Leif Sorensen, MD, a neuroradiologist with Aarhus University Hospital in Aarhus, Denmark.

Evasc Neurovascular’s eClips device is a nontubular endovascular device currently targeted for use in challenging wide-neck bifurcations. The device’s technology, which is designed to treat 95% of bifurcation aneurysm cases, provides both coil retention and flow diversion at the neck.

Treatment with eClips avoids dangerous entry into the dynamic and fragile environment of the aneurysm sac, leaves side branches unencumbered, and provides a platform for endothelial growth across the bifurcation neck, stated the company.